Benjamin Nathaniel Kaplan, CEO and Director of AIBotics Therapies, Inc., filed a statement of changes in beneficial ownership on November 18, 2026, disclosing a transaction dated October 29, 2026.

Key Highlights

  • Reporting person: Benjamin Nathaniel Kaplan, serving as both CEO and Director of AIBotics Therapies, Inc.
  • Transaction: 100,000,000 shares of common stock acquired (transaction code A) on October 29, 2026, at a price of $0.002 per share.
  • Purpose of issuance: According to the filing, shares were "received in lieu of cash for a portion of the filer's accrued salary."
  • Resulting ownership: Following the transaction, Kaplan held 195,250,000 shares of common stock directly.
  • Issuer trading symbol: The filing identifies the issuer as AIBotics Therapies, Inc., trading under the symbol AIBT.

Kaplan Receives Common Stock in Lieu of Cash Salary Payment

According to the filing, Benjamin Nathaniel Kaplan, who holds the roles of CEO and Director at AIBotics Therapies, Inc., acquired 100,000,000 shares of the company's common stock on October 29, 2026. The stated per-share price was $0.002. The filing notes that these shares were received "in lieu of cash for a portion of the filer's accrued salary," indicating a non-cash compensation arrangement rather than an open-market purchase.

Prior to this transaction, Kaplan's directly held position would have stood at 95,250,000 shares, based on the post-transaction total of 195,250,000 shares reported in the filing. AIBotics Therapies, Inc. is listed on the OTC market under the ticker symbol AIBT, as identified in the issuer field of this filing. The filing was signed by Benjamin Kaplan and submitted to the SEC on November 18, 2026, covering the earliest transaction date of October 29, 2026. No derivative securities were reported in Table II of the filing.

What Was Disclosed

The filing disclosed that CEO and Director Benjamin Nathaniel Kaplan acquired 100,000,000 common shares of AIBotics Therapies, Inc. at $0.002 per share on October 29, 2026, as compensation in lieu of accrued salary, bringing his direct beneficial ownership to 195,250,000 shares.